vxa-g2.4-ns
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 20, 2019 (NCT03897309)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- NorovirusImmunity, active
immunity, active - norovirus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06944717 | Phase 1 | Mar 3, 2025 | Vaxart |
| NCT07254728 | Phase 1 | Oct 27, 2023 | Vaxart |
| NCT03897309 | Phase 1 | Mar 20, 2019 | Rapid Medical Research, Inc., Vaxart |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vaxart | For profit | 3 | 3 | 1 | 2019 |
| Rapid Medical Research, Inc. | For profit | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1